BRAF and melanoma: Since the first description of BRAF mutations in melanoma (Davies et al., 2002) BRAFV600E, the most predominant mutant, has been shown to constitutively activate ERK in melanocytes, and to transform p16/INK4A deficient melanocytes (Wellbrock et al., 2004).